Review decision date: July 2016

Review decision:

We checked this guideline and decided that it should not be updated at this time. For details, see the update decision, summary of new evidence, response to stakeholder comments and the process for deciding if an update is needed.

Next review date: 2019

NICE has produced two guidelines on drug misuse – drug misuse in over 16s: psychosocial interventions (NICE guideline CG51) and drug misuse in over 16s: opioid detoxification (NICE guideline CG52). They cover: 

  • the support and treatment people can expect to be offered if they have a problem with or are dependent on opioids, stimulants or cannabis
  • how families and carers may be able to support a person with a drug problem and get help for themselves.

This guideline makes recommendations for the use of psychosocial interventions in the treatment of people who misuse opioids, stimulants and cannabis in the healthcare and criminal justice systems.

It was previously called drug misuse – psychosocial interventions.

NICE has produced joint information for the public that covers both guidelines, as well as tools to help organisations implement this guidance – these have been integrated with tools for other NICE guidance on drug misuse.

Your responsibility

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.

  • National Institute for Health and Care Excellence (NICE) accreditation logo